Phase 1b clinical trial

AVA6000 Demonstrates Tumor Shrinkage in Phase 1b SGC Trial

LONDON and PHILADELPHIA, December 17, 2025 — Avacta Therapeutics, a clinical-stage biopharmaceutical company, has reported positive Phase 1b clinical...

By cGxPwire Editor
December 17, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Phase 1b clinical trial

AVA6000 Demonstrates Tumor Shrinkage in Phase 1b SGC Trial